Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 1998

View Archived Issues

Allelix: Annual Report 1997

Cel-Sci on the way to developing a worldwide AIDS vaccine

Vion: Q4 and year-end 1997 highlights

SKB reveals new antiherpesvirus agents

Boehringer Ingelheim discloses new antiplatelet agents

Alendronate sodium: a promising therapeutic agent for the prophylaxis of postmenopausal bone loss

A new hypothesis may explain the high incidence of autoimmune disorders in women

Risedronate: a potential nonhormonal agent for the prevention of osteoporosis

Yamanouchi investigates orally active AII antagonists

Hoechst Marion Roussel and 3M establish marketing agreement for asthma products

Milkhaus receives patent protection for DNA treatment of respiratory disorders

British Biotech announces nine-month highlights

Patient enrollment completed for phase I/II pancreatic cancer trial

Use of aspirin to prevent preeclampsia should be discontinued, NIH researchers say

FDA approves low-dose Estratab for osteoporosis

Phase III results reported for Cellegy's Glylorin

INVICORP shows 70% efficacy in ED study

Neuronal SK(Ca) channel blockers prepared at U.K. university

Alpha-Beta Technology: Q4 and year-end highlights

Method of diagnosing Hodgkin's disease disclosed by cancer research institute

Lilly enters genomics alliance for type II diabetes and obesity research

SmithKline Beecham develops new anticonvulsants

Omniferon enters preclinical studies

COX-2 inhibitor displays chemopreventive effects in rats

Patient enrollment complete for MS-325 phase II trial

Genentech and DAKO establish development agreement for HER2 detection

Intercardia to license IBD drug

Ishihara Sangyo speeds up development of new drugs